| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2020 | Feb 20, 2020 | Latkin Jed CEO COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $1.08 | $5,400 | +21.79% |
| Jun 05, 2019 | Jun 07, 2019 | Latkin Jed CEO COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $1.26 | $1,258 | +7.17% |
| May 16, 2019 | May 17, 2019 | Latkin Jed CEO COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $1.46 | $3,643 | +17.30% |
| May 13, 2019 | May 15, 2019 | Latkin Jed CEO COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $1.8 | $9,721 | +36.36% |
| May 30, 2017 | May 31, 2017 | Latkin Jed COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $0.44 | $3,317 | +13.16% |
| May 19, 2017 | May 23, 2017 | Latkin Jed COO CFO | Buy | Navidea Biopharmaceuticals, Inc. | NAVB | $0.45 | $11,426 | +37.34% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.